REPL
Replimune Group, Inc. · Healthcare
Director Philip Astley-Sparke sold $90K of Replimune Group, Inc.
Sold$89,698
$5.08Price
17,657Shares
−1%Stake
What REPL did after the filing
- The stock from Thu, May 21 open, $5.07
- +127.0%
- S&P 500, same days
- +1.2%
Measured over 30 trading days, to the Jul 7 close.
Traded Mon, May 18. Filed Wed, May 20, 4:16 PM ET, after the close. Returns use the May 21 open and the Jul 7 close. Not investment advice.